4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Eton Pharmaceuticals, Inc. (ETON) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Deer Park, United States with about 44 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, ETON reported $80M in revenue and ($5M) in net income.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Interactive charts & full statements → Open the ETON valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $80M | $39M | $32M | $21M | — |
| Gross Profit | $43M | $23M | $21M | $14M | — |
| Operating Income (EBIT) | ($1M) | ($3M) | ($1M) | ($8M) | — |
| Net Income | ($5M) | ($4M) | ($1M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $24M | $21M | $22M | $19M | $17M |
| Gross Profit | $15M | $13M | $8M | $12M | $10M |
| Operating Income (EBIT) | $2M | $2M | ($1M) | ($2M) | ($0M) |
| Net Income | $2M | $2M | ($2M) | ($3M) | ($2M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $92M | $76M | $32M | $25M | — |
| Total Liabilities | $66M | $52M | $16M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ETON viewer.
About TickerBase · Data methodology & sources